From 2018 to 2020, Suzhou Key Laboratory for Metabolic Syndrome New Drug Research made several achievements in paper publication, talent training and industrial cooperation.
The laboratory has published a number of scientific research papers with impact factors of 10 or greater, including four Essential Science Indicator (ESI) Top 1% highly cited papers. Some papers have been published in international top journals, including Science, Cell, and Nature Communications. Many key achievements are at world-class level in the field.
In terms of industrial cooperation, the laboratory has completed a number of projects with enterprises, including Innocent Biopharmaceutical, the First Affiliated Hospital of Soochow University, and Suzhou Precision Medical Technology Co., Ltd.
From 2018 to 2020, Suzhou Key Laboratory for Metabolic Syndrome New Drug Research made several achievements in paper publication, talent training and industrial cooperation.
The laboratory has published a number of scientific research papers with impact factors of 10 or greater, including four Essential Science Indicator (ESI) Top 1% highly cited papers. Some papers have been published in international top journals, including Science, Cell, and Nature Communications. Many key achievements are at world-class level in the field.
In terms of industrial cooperation, the laboratory has completed a number of projects with enterprises, including Innocent Biopharmaceutical, the First Affiliated Hospital of Soochow University, and Suzhou Precision Medical Technology Co., Ltd.